Search results (3290)
« Back to PublicationsDNA prime and peptide boost immunization elicits robust neoantigen-specific CD8 + T cell responses and therapeutic protection in mouse tumor models.
Journal article
Morgado-Cáceres P. et al, (2026), Oncoimmunology, 15
Engineering and improving anti-CTLA-4 checkpoint inhibitors.
Journal article
Galvez-Cancino F. et al, (2026), Clinical cancer research : an official journal of the American Association for Cancer Research
Ensuring vaccine cold chain integrity: A rapid and low-cost test for identifying heat-exposed sucrose-containing vaccines.
Journal article
Arman BY. et al, (2026), International journal of pharmaceutics: X, 11
BOA constrictor: a Mamba-based lossless compressor for scientific data
Journal article
Gupta A. et al, (2026), Machine Learning Science and Technology, 7
Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I
Journal article
Murali TM. et al, (2026), Discovery Immunology
Economic evaluation of alternative hepatitis C treatment options: a post hoc analysis of the VIETNARMS trial.
Journal article
Turner HC. et al, (2026), EClinicalMedicine, 95
HLA-E-restricted T cells primed by a modified HLA-B*57:01 restricted HIV-1 peptide suppress HIV-1 replication.
Journal article
Sun H. et al, (2026), JCI insight
Safety and activity of RO7300490, a bispecific CD40 agonist targeted to fibroblast activation protein, in patients with advanced solid tumors: a single-arm, multicenter, first-in-human, phase 1 trial.
Journal article
Melero I. et al, (2026), Nature cancer
Nonclassical MHC-I Molecules: Emerging Therapeutic Targets in Next-Generation Immunotherapy.
Journal article
He W. and McMichael AJ., (2026), MedComm, 7
A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanoma.
Journal article
Garralda E. et al, (2026), Clinical cancer research : an official journal of the American Association for Cancer Research
Cibisatamab and FAP-4-1BBL in microsatellite-stable colorectal cancer: a phase 1b trial.
Journal article
Melero I. et al, (2026), Nature medicine
Upstream ORFs control TNFR1 abundance and tissue tolerance to TNF.
Journal article
Ma B. et al, (2026), Science immunology, 11
Using peptide-exchange systems to interrogate peptide-specific KIR binding to HLA Class I
Preprint
Murali TM. et al, (2026)
Intratumoral heterogeneity and immunotherapy resistance: clinical implications.
Journal article
Keenan BP. et al, (2026), Annals of oncology : official journal of the European Society for Medical Oncology, 37, 314 - 328
Safety, Feasibility, and Pharmacodynamic Activity of Intratumoral Injections of the Agonist Anti-CD137 (4-1BB) mAb Urelumab in Combination with Nivolumab.
Journal article
Sanmamed MF. et al, (2026), Clinical cancer research : an official journal of the American Association for Cancer Research, 32, 1036 - 1045